Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
Study Information
Alliance Study ID: CALGB-40105
NCT Study ID (ClinicalTrials.gov): NCT00045591
Alliance Committee: Breast Cancer
Disease or Cancer Type: Breast Cancer
Alliance Study Chair: Charles L. Shapiro, MD
Status: TERMINATED
Study Description
RATIONALE: Celecoxib may stop the growth of tumor cells by blocking the enzymes necessary for their growth and by stopping blood flow to the tumor. It is not yet known which regimen of celecoxib is more effective in treating breast cancer.
PURPOSE: Randomized phase II trial to compare the effectiveness of two regimens of celecoxib in treating women who have metastatic or recurrent breast cancer
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information